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Available online 5 July 2012Abstract Multiple signalling pathwaysmaintain human embryonic stem cells (hESC) in an undifferentiated state. Here we sought to
define the significance of G protein signal transduction in the preservation of this state distinct from other cellular processes.
Continuous treatment with drugs targeting Gαs-, Gα-i/o- and Gα-q/11-subunit signalling mediators were assessed in independent hESC
lines after 7 days to discern effects on normalised alkaline phosphatase positive colony frequency vs total cell content. This identified
PLCβ, intracellular free calcium and CAMKII kinase activity downstream of Gα-q/11 as of particular importance to the former. To
confirm the significance of this finding we generated an agonist-responsive hESC line transgenic for a Gα-q/11 subunit-coupled receptor
and demonstrated that an undifferentiated state could be promoted in the presence of an agonist without exogenously supplied bFGF
and that this correlated with elevated intracellular calcium. Similarly, treatment of unmodified hESCs with a range of intracellular
free calcium-modulating drugs in biologically defined mTESR culture system lacking exogenous bFGF promoted an hESC phenotype
after 1 week of continuous culture as defined by co-expression of OCT4 and NANOG. At least one of these drugs, lysophosphatidic acid
significantly elevates phosphorylation of calmodulin and STAT3 in this culture system (pb0.05). These findings substantiate a role for
G-protein and calcium signalling in undifferentiated hESC culture.
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172 A. Ermakov et al.IntroductionMaintenance of human embryonic stem cells (hESCs) in an
undifferentiated state is realised by a multitude of extrinsic
factors whose effects are mediated by overlapping intra-
cellular signal transduction pathways. Those implicated to
date have included pathways stimulated by ligands such as
basic Fibroblast Growth Factor (bFGF), Wnt and members of
the Transforming Growth Factor Beta (TGFβ) superfamily
(Okita and Yamanaka, 2006). Binding of bFGF to its cognate
receptor normally results in activation of receptor tyrosine
kinase activity and subsequent stimulation of the Ras-
activated mitogen-associated protein kinase (MAPK),
phosphatidylinositol-3 kinase (PI3K)/Akt/Protein kinase B
(PKB) and Phospholipase C-gamma (PLC-γ) pathways, the
former two of which have been shown to be active in hESCs
(Dvorak et al., 2005; Kang et al., 2005) In contrast, binding
of Wnt proteins to cell surface receptors of the Frizzled
(FZD) family activates Dishevelled family proteins which in turn
inhibit a complex of proteins (axin/GSK3/APC) responsible for
the proteolytic degradation of the β-catenin intracellular
signalling molecule and transcription co-factor. Stabilising the
cytoplasmic pool of β-catenin by pharmacological inhibition of
GSK3 promotes embryonic stem cell renewal (Sato et al., 2004).
In addition, TGFβ and Nodal, expressed by undifferentiated
hESCs, and Activin-A, normally secreted by fibroblast feeders
which are supportive of hESC renewal, all work to oppose
induction of trophoblast/primitive endoderm differentiation by
Bone Morphogenic Protein (BMP)-4, another member of the
TGFβ superfamily (Beattie et al., 2005; Sato et al., 2003).
This is mediated by the activation of different cell surface
receptors (Type II vs I) and downstream transcription factors
(SMAD2/3 vs SMAD1/5/8) (James et al., 2005; Valdimarsdottir
and Mummery, 2005).
Understanding the means by which the diverse pathways
governing hESC fate can be modulated by extrinsic factors
and the relative importance of other signal transduction
pathways to mediate these effects is of importance for the
development of safe and efficacious culture systems. A
fundamental starting point with which to advance this
understanding is to focus on heterotrimeric GTP-binding (or
G) protein signalling. G-proteins, composed of α, β, and γ
subunits, are central components of primary mechanisms
used by virtually all cells to respond to structurally and
chemically diverse extracellular stimuli (e.g. ions, amino
acids, peptides, nucleotides, lipids, biogenic amines, light)
in diverse contexts including development and cancer
(reviewed in (Dorsam and Gutkind, 2007; Malbon, 2005).
Signalling via specific subunits and isoforms is classically
understood to be coupled to heptahelical or seven trans-
membrane spanning receptors (also known as G protein-
coupled receptors, GPCRs), but can also be coupled with other
types of receptor including single transmembrane spanning
tyrosine kinase receptors for growth factors such as EGF, PDGF,
insulin, and IGFs and extracellular proteins such as integrins
(reviewed by (Patel, 2004).
G-protein signal transduction is well established. In the
resting state, the Gα subunit is bound to GDP and is associated
with the Gβ and Gγ subunits. Upon ligand binding, an associated
receptor activates the trimeric G protein that it is coupled to,
resulting in GDP to GTP exchange and dissociation of the Gαfrom Gβ and Gγ subunits followed by Gα and βγ subunit binding
to and activation of respective effectors. Gα subunits are
divided into four groups based on their sequence homology and
their immediate effector function; Gαs and Gαi/o subunits
stimulate or inhibit adenyl cyclases and the production of cAMP
second messengers, respectively, with certain members of the
latter also regulating cGMP-gated Na+/Ca++ channels. The
Gαq/11 subunit stimulates phospholipase C-β (PLC-β) and the
production of the second messengers’ inositol triphosphate
(IP3) and diacylglycerol (DAG). And, the Gα12/13 subunits
stimulate the low-molecular-weight G protein Rho and its
downstream targets. Lastly, βγ subunit complexes appear to
activate/associate with a broad range of effectors including
Na+, K+ and Ca++ ion channels, mitogen-activated protein
kinases, adenyl cyclases, PLC-β and ε and small G proteins
(reviewed by (McCudden et al., 2005).
Despite the fundamental role for G proteins in signal
transduction, their significance to embryonic stem cell
renewal remains relatively unexplored. In mESCs blocking
or stimulation of metabotropic glutamate receptors acting
via the Gαq subunit inhibits the expression of pluripotency
transcription factors OCT4 and NANOG or sustains ESC
renewal, respectively (Cappuccio et al., 2005). In hESCs,
the mitogenic GPCR ligand sphingosine-1-phosphate (SIP)
synergistically stimulates self-renewal with PDGF in serum-
free medium (Pebay et al., 2005). In the present study we
hypothesised that the significance of G-protein mediated
signal transduction pathways to hESC renewal could be
discriminated using pharmacological drugs whose effects on
these pathways have been well characterised. To confirm
this we performed independent primary screens involving
continuous treatment of hESCs over 7 days with drugs at a
range of concentrations applied under self-renewal condi-
tions. This was followed by an assay to discriminate un-
differentiated alkaline phosphatase positive hESCS from
total cells. This identified pathways downstream of the Gαi-o
and Gαq subunits and particularly free intracellular calcium
concentration ([Ca++]i) as important for undifferentiated
hESC maintenance. This was confirmed using a transgenic
hESC model and diverse small molecule effectors of in-
tracellular free calcium, whose effect on the phosphorylation
of downstream kinases we assessed. Our study substantiates a
role for G-protein and calcium signalling in hESC self-renewal
and future investigations to explore the means to manipulate
these pathways in order to maintain undifferentiated hESCs in
long term culture.
Materials and methods
hESC culture
RH1, RH6 and RCM1 human embryonic stem cells (hESC)
were isolated under a licence held by PDS from the UK
Human Fertilisation Embryology Authority and deposited in
the UK Stem Cell Bank (Fletcher et al., 2006; De Sousa et al.,
2009). Their use in this project was approved by the UK Stem
Cell Bank steering committee. Unless otherwise stated,
reagents were sourced from Invitrogen (Paisley, UK).
Drug screening experiments were performed in feeder-free
conditions on growth factor-reduced Matrigel (MG, Becton
Dickinson, Oxford, UK) diluted 1:30 in “Knockout” Dulbecco's
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either a human neonatal foreskin dermal fibroblasts (HDFs;
Cascade Biologics, Nottinghamshire, UK) conditioned and
Knock-out serum replacement (KOSR™, Invitrogen) supple-
ment DMEM as described by Fletcher et al. (2006) and based
on the method of Xu et al. (2001), or mTESR prepared with
(Ludwig et al., 2006) or without bFGF.
Agent treatment
Unless stated otherwise, plating of cells for agent treat-
ments was performed as follows: adherent cultures were
treated with Trypsin-EDTA (0.025% Trypsin and 0.01% EDTA
in PBS) for 10 min. The trypsin was neutralised and the cells
disaggregated by trituration. 10,000 hESCs per well were
plated in 24 well plates coated with MG. Agent treatments
were started 24 h after plating and lasted for 6 days. Culture
medium (containing treatment or vehicle control) was ex-
changed daily.
Alkaline phosphatase staining
Alkaline phosphatase (AP) staining was performed on cells
fixed for 2 min with 4% paraformaldehyde in PBS using an AP
Detection Kit (Chemicon, Hampshire, UK) according to the
manufacturer's instructions. For quantification, a colony
consisting of 4 or more closely packed cells, which were
clearly positive for AP, was defined as an AP+ colony (See
Fig. 2B).
SRB staining for protein quantification
Fixation was performed in 24 well plates by adding 0.5 ml 25%
TCA to adherent cells covered with 1 ml PBS. The fixative was
removed after a 60 min incubation at 4 °C and the cells were
washed 10 times with dH2O. The cells were air-dried at 40 °C.
Once dry cells were treated with SRB solution for 30 min at
room temperature according to the manufacturer’s recom-
mendations (Sigma Aldrich). This was followed by 4 washes
with 1% glacial acetic acid and a second cycle of drying at 40 °C.
The protein-incorporated dye was solubilised for 60 min in
250 μl 10 mM Tris HCl, pH 10.5. 200 μl of the resulting solution
was transferred to a 96well plate and the absorbance at 540 nm
was read using a Labsystems Multiscan EX plate reader (MTX Lab
Systems, Inc., Virginia, USA).
Fluorescent staining for flow cytometry and [Ca++]i
measurements
Single cell suspensions of cultured cells were prepared by
treatment with TrypLE Select (Invitrogen, Paisley, UK) for
5–10 min at 37 °C. 2.5×105 cells were aliquoted, harvested by
centrifugation at 300 g and resuspended in 0.5 ml KO-DMEM
each. Cells were stained with 8 ng/ml of Fluo3 (Molecular
Probes, Eugene, USA) and 20 ng/ml of Fura2 (Molecular Probes,
Eugene, USA), both for 20 min on ice, and collected by
centrifugation at 300 g for 5 min. The resuspended pellets
were then consecutively incubated with primary (1:125,
anti-mouse SSEA-4, DSHB MC-813-79, Developmental Studies
Hybridoma Bank, Iowa, USA) and secondary (1:125, goatanti-mouse IgG3 FITC, Caltag Medsystems, Buckingham, UK)
antibodies for 20 min on ice. The cells were harvested by a
final centrifugation at 300 g and resuspended in FACS-PBS
(0.1% FCS, 0.1% NaN3 in PBS). The samples were analysed
using a FACS Calibur instrument (Becton Dickinson, NJ,
USA). Controls for SSEA-4 staining were incubated without
primary antibody. The relative level of [Ca++]i was estimat-
ed on the basis of the mean Fura2:Fluo3 ratio.Generation of a rat gonadotropin releasing hormone
receptor expressing transgenic hESC line
A single cell suspension of 1–1.5×106 RH1 hESCs was
transfected by electroporation at 320 V, 200 μF using a
Biorad Gene Pulser II electroporator with 50 μg pcDNA3-
rGNRHR-I linear plasmid DNA in PBS. The plasmid pcDNA3-
rGNRHR-I contains the rat GNRH receptor (rGNRHR) under
the control of the strong constitutive CMV promoter (Fig.
S3A). Cells were plated out onto Matrigel-coated 10 cm
diameter tissue culture dishes and after 48 h the medium
was supplemented with 100 μg ml−1 G418. G418-resistant
colonies with a normal hESC morphological phenotype (Fig.
S3B) were picked after 14 days, expanded on irradiated HDFs
in the absence of G418 and after establishment as indepen-
dent lines were transferred back to feeder-free conditions.
Responsiveness to GNRH was assessed by means of a Fluo-
3-based Flurometric Image Plate Reader assay (FLIPR assay,
Molecular Devices, Sunnyvale, California), according to the
manufacturer's instructions.Effect of Ca++ ATPase inhibitory drugs on hESC self
renewal by high content screening
mTeSR-adapted RH1 hESCs were plated in a 96 well tissue
culture plate as single cells at a density of 104cells/well
(0.35 cm2) equivalent to approximately 10% confluence. The
following day cells were switched to mTeSR lacking bFGF
(Stemcell Technologies) but containing cyclopiazonic acid,
thapsigargin, LPA, Clotrimazole or Chlorpromazine at one of
three different concentrations for 7 days (Table S2). All
conditions were set up in quadruplicate, with vehicle
controls (DMSO for CPA, thapsigargin, Clotrimazole and
Chlorpromazine, medium for LPA) at the same concentration
in parallel. After 7 days' culture, with daily medium
changes, the wells were washed, fixed in 4% PFA/PBS for
20 min and permeabilised with 0.2% Igepal/PBS for 20 min.
The cells were immunostained consecutively for OCT4 (Santa
Cruz mouse monoclonal IgG), with a secondary antibody
conjugated to alexafluor-488 (green, Invitrogen) and NANOG
(Goat anti-human NANOG, R&D systems), with a secondary
antibody conjugated to alexafluor-555 (red, Invitrogen), and
counterstained with DAPI. The plates were scanned in the
red, green and blue channels with a confocal microscope-
based Opera high-content screening system (Perkin-Elmer),
imaging 9 non-overlapping fields for each well. There were
approximately 800–1000 nuclei field−1 in a sub-confluent
well in non-toxic conditions. Counts of nuclei positive for a
signal in one or more channels were made using an in-house
customised version of the nuclei counting script in Acapella
software (Perkin Elmer). Counts of OCT4 and NANOG double
174 A. Ermakov et al.positive cells for each treatment were normalised relative to
its respective vehicle control.
Assessment of phosphorylation of intracellular
substrates by western immunoplotting
Twenty four hours after plating RH1 hESC, the cells were
treatedwith 10 μMof Clotrimazole (C), 2.5 μMof Cyclopiazonic
acid (CPA), 3 μM of Chlorpromazine (Ch), 100 nM Lysophos-
phatidic acid sodium salt (LPA), 1 nM of Thapsigargin (T) in
mTESR lacking bFGF and TGF-b. No Growth factors with or
without DMSO at 0.01% (vehicle) served as negative controls,
the latter for all drugs except for LPA. As positive controls, bFGF
or TGF-β was each added to a final concentration of 15 ng/ml
alone or with each other. After 10 min, and 3 and 24 h of
treatment cell bioactivity was stoppedwith ice cold PBS and the
cells were lysed and scraped off with 100 μl/100 mm dish of
RIPA (RadioImmuno Precipitation Assay) buffer (10 mMTris–HCl
at pH7.4, 1 mM EDTA, 150 mM NaCl, 1% NP40, 0.1% SDS, 0.1%
Sodium Deoxycholate) supplemented with protease and phos-
phatase inhibitors (Sigma-Aldrich, Dorset, UK). Following BCA
(Bicinchronic Acid) protein quantification of cell samples using
the manufacturer’s recommended protocol (Pierce-Thermo
Scientific, Rockford IL, USA), separation on 12% polyacrylamide
gel and transfer to a nitrocellulose membrane blocked with 3%
BSA in TBST blots were probed with antibodies to active
phosphorylated forms of Calmodulin, CamKII, Smad2, ERK and
Stat3 and non-phosphorylated SHPT2 as a control for protein
loading, followed by antibodies to rabbit or mouse Horseradish
peroxidise (HRP) conjugated secondary antibodies and enzy-
matic chemiluminescence as per supplier's recommendations
(Pierce-Thermo Scientific, Rockford IL, USA). Membranes were
washed and stripped of antibodies using Pierce RestoreWestern
Blot Stripping Buffer. Then they were washed, blocked and
reprobed repeating the immunodetection protocol. Substrate
specific signal intensity was quantified from digital images of
blots using Adobe Photoshop. Further details on the antibodies
used are provided in Supplementary Table S3.
Statistical analysis
Statistical analysis was performed using GraphPad Prism. In
drug and smallmolecule screening andWestern blot assessment
of intracellular substrate phosphorylation, differences between
control and treated samples were assessed by one-way ANOVA
followed by unpaired t-tests. A paired Student's t-test was used
to evaluate the significance of [Ca++]i differences observed
between SSEA4+ and SSEA4- cells. Statistical significance varied
from pb0.001 (denoted by pbb0.01) to pb0.05.
Results
Drug screening implicates Gα-i/o and Gα-q/11 subunit-
linked signal transduction in undifferentiated hESC
renewal
To screen for G protein signal transduction pathways of
particular importance for undifferentiated hESC maintenance
we developed a short term culture assay to assess the effects
of pharmacological drugs and ligands known to affect thesepathways (Fig. 1; Supplementary Table S1, Fig. S1). This assay
involved the assessment of the proportion of phenotypic
hESCs, scored by counting colonies positive for alkaline
phosphatase (AP+) relative to total cell content, after 7 days
of treatments in feeder-free culture conditions. The objective
was to identify agents demonstrating a concentration depen-
dent effect restricted to AP+ colony frequency distinct from
effects on total cell content, the latter reflective of overall
effects on cell adhesion, growth or death. All agents were
tested at least twice in independent experiments on the RH1
hESC line used to develop the assay. In the case of the first
primary screen of the Gαq/Phospolipase C-β/Protein Kinase C
(Gαq/PLCβ/PKC) pathway, results were also confirmed in an
independent cell line, RH6 (Fletcher et al., 2006). Only results
on RH1 whose statistical significance was independently
verified in the same line and RH6 are reported. Drugs were
applied at low, medium and high concentrations, with the
highest concentrations at the IC/EC50 for the drug target, i.e.
the concentration causing half-maximal inhibition or activa-
tion of the target (Supplemental Table S1). In each experi-
mental trial, drug-free or vehicle controls (e.g. DMSO or
propylene glycol) were evaluated, the latter at concentrations
corresponding to those used for drug treatment. Overall, the
mean frequency of AP+ colonies per well in experimental
controls ranged from 10 to 100, with a mean of 25. This
corresponded to an AP+ colony/1000 cell ratio of 0.1 to 0.6.
Given variation in absolute and normalised values between
experiments, and the necessity to test a range of vehicle
concentrations tomatch drug treatments, results are reported
in terms of differences (Delta, Δ) relative to vehicle-matched
control treatments for both total cells and normalised AP+
Colony Frequency (Top vs Bottom panels for Figs. 1B, 2A, and
Supplementary Fig. S2).
In the first screen of agents affecting pathways down-
stream of all three Gα subunits (Gαq, Gαs, Gαi/o) or agonists of
Gαq-mediated GPCRs pathways (MPEP for mGluR5 and Kiss-
peptin for GPR54), 6 agents induced a significant change (Δ) in
a concentration dependent manner in either or both Total Cell
Counts or Mean Normalised AP+ Colony Frequency as com-
pared to respective controls (Fig. 1B). For the Gαq/PLCβ/PKC
pathway, inhibition and activation of PKC using Ro31-8220 and
PMA, respectively, reduced total cell counts at higher. At
these concentrations, PMA also reduced the mean normalised
AP+ colony frequency, although only the lowest concentration
reduced AP+ colony frequency alone. This was further
confirmed in a subsequent evaluation of lower doses (0.01 to
1 nM) with no effects at less than or equal to 0.2 nM
(Supplementary Fig. S2). In the first screen, the pan-PLC
inhibitor U73122 also only affected normalised AP+ colony
frequency alone at the lowest concentration tested (2 μM).
Medium and higher concentrations of U73122 necessitated
DMSO vehicle at 0.5% and 2.3% which was cytotoxic (denoted
by crucifix Fig. 1B) and did not support AP+ colony formation
even in vehicle controls (data not shown). The specificity of
the effect on AP+ colony formation achieved using low
concentrations of the Pan-PLC inhibitor were further evaluat-
ed using the weak analogue of U73122, U73343, at a lower
concentration range (1, 2, 5, 7, 10 μM; Supplementary Fig.
S2). At all concentrations of the analogue and 5 μM or higher
concentrations of U73122, there were reductions in both total
cells and normalised AP+ colony frequency relative to
controls. However, AP+ colony frequency alone was reduced
Figure 1 G-protein signalling pathway modulators and significant outcomes of primary screen. (A) Table showing the list of drug
compounds and receptor agonists used in this study, together with their targetmolecules, specific pathways and their effects. (B) Summary
of replicated significant changes (Δ) in total cells (top panel) and AP+ colony frequency normalised to total cells (bottom panel) between
drug treatments and respective vehicle or untreated control. Stars indicate the level of significance (*pb0.05; **p≤0.01;
***pbb0.001). A crucifix indicates toxicity so high that a calculation could not be performed. The signalling pathway of which the drug
target is a component is indicated. The range of compound concentrations (shaded triangle) tested was as summarised in Supplementary
table 1 and did not exceed the IC/EC50 (half-maximal inhibitor/activating) concentration for each compound.
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Figure 2 Modulation of free intracellular calcium and its effectors. (A) Summary of independently replicated significant changes
(Δ) in total cells (top panel) and AP+ colony frequency normalised to total cells (bottom panel) between drug treatments targeting
the Gαq-PLCβ-PKC pathway and respective vehicle or untreated control. Stars indicate the level of significance (* pb0.05; ** p≤0.01;
***pbb0.01). Calculation of significance not applicable (n/a) in instances where no AP+ colonies were detectable following
treatment. The range of compound concentrations (shaded triangle) tested was as summarised in Supplementary table 1 and did not
exceed the IC/EC50 (half-maximal inhibitor/activating) concentration for each compound. (B) Representative AP+ colony staining
after 6 days of hESC treatment with vehicle control (i), the SERCA inhibitors cyclopiazonic acid (ii) and thapsigargin (iii), the
free-calcium chelator BAPTA (iv), the calceneurin inhibitor cyclosporin (v) and the CAMKII kinase inhibitor KN-62 (vi). Bar equals
100 μm. (C) Representative experiment depicting mean intracellular Ca++ levels determined by Fura2:Fluo3 ratios in SSEA4+/− cells
following treatment with (+) or without (−) Thapsigargin for 24 h. Mean±S.D, n=4, asterisk denotes statistical significance of pb0.05
following a paired t-test. No significance is denoted by "ns".
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177Role for G-Protein and calcium signalling in hESCsat 2 μM U73122, with no effects at 1 μM. Neither of the
Gαq-mediated GPCR effectors (MPEP and kisspeptin) had any
differential effects versus controls on either total cell number
or normalised AP+ colony frequency. According to Robust
Multi-array Average (RMA) expression matrix analysis of
affymetrix mRNA hybridisation data sets previously generated
by our laboratory for RH1 and RCM1, another cell line cultured
under similar conditions (De Sousa et al., 2009) the target
ligands for these agents, GluR5 and GPR54 respectively, are
expressed suggesting they are not implicated in hESC growth or
renewal (Supplementary Fig. S3). The global Gαq inhibitor
YM-254890 also did not have any effect. This suggests that
neither these agonists nor the Gαq/11 subunit is normally
implicated in undifferentiated hESC renewal or viability, at
least in the culture conditions in which the assay was
performed.
For agents affecting the Gαs-Adenyl Cyclase–Protein Kinase
A (Gαs-AC–PKA) pathway, medium and high concentrations of
forskolin (cAMP activator) and 4C3MQ (PKA inhibitor) decreased
and increased total cell numbers, respectively, without any
apparent affects on normalised AP+ colony frequency. Cholera
toxin, a Gαs activator, had no effects at all concentrations
tested. These findings suggested that the Gαs-AC–PKA pathway
may be of less significance to hESC renewal per se. For the Gα-i/o
pathway we only evaluated pertussis toxin, a direct inhibitor of
the Gα-i/o subunit. Low andmedium concentrations of this agent
affected both total cell and normalised AP+ colony frequency,
although the highest concentration (500 ng/ml) affected only
the latter.Involvement of intracellular free calcium and CAMKII
kinase in undifferentiated hESC maintenance
A principle observation from the primary screen was the ability
to achieve a specific reduction in normalised AP+ colony fre-
quency without concurrent effects on total cells, using a Pan-
PLC inhibitor (U73122) at low concentrations. We thus focused
on downstream elements to this pathway in our pursuit of signal
transduction of most relevance to hESC renewal. PLC signal
transduction occurs via the phosphatidylinositol-2-phosphate
(PIP2)-mediated cleavage products DAG (which activates PKC)
and IP3 (which increases intracellular free calcium) (Berridge
and Irvine, 1984). As treatment with the PKC inhibitor Ro31-
8220, did not appear to interfere with AP+ colony formation we
focused on signalling mediated by free intracellular calcium.
By RMA analysis, RH1 and RCM1 hESCs cultured under
feeder-free conditions as used in this study expressed of two
out of three sarco/endoplasmic reticulum Ca++ ATPase (SERCA)
pumps (2 and 3) and IP3 receptors (ITPR 2 and 3) necessary for
mediating calcium signal transduction. They also express most
LPA receptors (LPAR1-4 and 6 and S1PR2-5) but not any of the
three Ryanodine receptors (Supplementary Fig. S3). Thapsi-
gargin and cyclopiazonic acid (CPA) are SERCA inhibitors and
thus have the potential to raise intracellular free calcium con-
centration, [Ca++]i, by inhibiting uptake of Ca++ ions to stores in
the ER. In two independent experiments on the RH1 hESC line,
treatment with thapsigargin and CPA reduced both Total Cells
and normalised AP+ colony frequency at most concentrations
tested. However, both agents increased AP+ colony frequency
at lower concentrations (Figs. 2A and B). Treatment withLysophosphatidic Acid (LPA), an agonist of LPA receptors on
surface membranes, whose activation can increase free
intracellular calcium, did not appear to have any effect on
hESCs at low and medium concentrations but increased the
normalised total cell number at high concentrations. Converse-
ly, treatment with the calcium chelator BAPTA reduced total
cells and normalised AP+ colony frequency at most concentra-
tions, but only the latter at lower concentrations (1–2 μM;
Figs. 2A and B).
The effects of free intracellular calciummay bemediated by
protein phosphorylation which can be controlled by a family of
calcium/calmodulin-dependent protein kinases (CAM kinases or
CAMK) and phosphatases. In two independent experiments
treatment with cyclosporin (CY), an inhibitor of the calcium-
dependent protein phosphatase calcineurin, decreased only the
normalised number of total cells at all concentrations evaluat-
ed. In contrast the CAMKII inhibitor KN-62 decreased only the
normalised AP+ colony frequency, suggesting it may be of
greater significance to maintenance of an undifferentiated
state as assessed by AP+ colony formation (Figs. 2A and B).
If intracellular free calcium signalling is more important
to hESC renewal than to differentiating cells we reasoned
this might be reflected by a higher [Ca++]i in the self-
renewing stem cell fraction of an hESC culture. We tested
this by quantifying the relative levels of [Ca++]i by Fura-2:
Fluo3 loading of stem cell marker SSEA4 +ve versus −ve
the latter putatively representing differentiating cells. In
two independent experiments on RH1 hESC grown under
self-renewal conditions consisting of fibroblast conditioned
medium, as for the screening experiments, intracellular free
calcium levels were significantly greater in SSEA4 positive
cells (pb0.05). This difference was lost if hESCs were first
treated with 10 nM Thapsigargin for 24 h prior to analysis
(Fig. 2C).Activation of an exogenously supplied Gα-q/11
subunit-coupled GPCR can compensate for a lack
of exogenously supplied bFGF in hESC renewal
To experimentally validate a potential role for calcium
signalling in hESC renewal the RH1 hESC line was transfected
with an expression construct containing the rat Gαq-coupled
GnRH receptor (Supplementary information, Fig. S3A), which is
otherwise not expressed in hESCs (data not shown). G418-
resistant subclones were discriminated as GnRH responders
(clone 4.2) and non-responders (clone 3.2) by assessment of
agonist induced elevation of intracellular calcium quantified by
Fura2/Fluo3 relative fluorescence unit (RFU) ratio measure-
ment over time (Fig. 3Ai). Responder and non-responder hESC
clones were subjected to the same assay used in the primary
drug screen, in a human dermal fibroblast-conditioned medium
either supplemented with 4 ng ml−1 bFGF (HDF-CM+) or with
no added bFGF (HDF-CM−), and GnRH at 20, 200 or 500 nM
(solid bars) or vehicle alone (clear bars) (Fig. 3Aii). In HDF-CM+,
there was no significant difference in normalised AP+ colony
frequency between GnRH- or vehicle-treated cells for both
clones. The same was the case for the non-responder clone 3.2
in HDF-CM−. However, for the responder clone 4.2 in HDF-CM−
(i.e. lacking exogenous bFGF), GnRH treatment signifi-
cantly increased normalised AP+ colony frequency at all
concentrations.
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drugs obviates the requirement for bFGF in defined
medium in short term culture
A prediction of the hypothesis that raising [Ca++]i promotes
maintenance of an undifferentiated hESC phenotype is that
medically-prescribed drugs known to inhibit Ca++ sequestration
by SERCA Ca++ATPases, should promote hESC self-renewal. Twosuch drugs approved for use in humans are chlorpromazine and
clotrimazole (Bartolommei et al., 2006; Hwang et al., 2001).
Our initial experiments with the GnRH-R transgenic hESC line
suggested that GPCR-mediated signalling could be used to
artificially compensate for a lack of exogenously supplied bFGF.
However, since the human dermal fibroblast conditioned
medium used in that experiment was supplemented with
4 ng ml−1 bFGF at the time of conditioning and the amount of
179Role for G-Protein and calcium signalling in hESCsbFGF removed and/or produced during conditioning by the
HDFs themselves, if any, is unknown, the exact bFGF
concentration in HDF-CM+ is also unknown. We therefore
decided to test this hypothesis in a definedmedium completely
lacking bFGF. RH1 hESCs that had been transitioned to an
mTeSR1 (Ludwig et al., 2006) (Stem Cell Technologies, Van-
couver, Canada)-based culture environment were cultured in
the presence of SERCA inhibitors (CPA, thapsigargin, clotrima-
zole or chlorpromazine) or LPA to activate surface GPCRs for
7 days in mTeSR1 lacking bFGF. The cells were then fixed and
immunostained for OCT4 and NANOG as a direct indicator of an
undifferentiated state, rather than the proxy of AP activity
employed previously. The proportion of nuclei staining for both
nuclear markers was taken as a measure of the proportion of
undifferentiated hESCs present, and thus the level of self
renewal in each culture. CPA, LPA, clotrimazole and chlor-
promazine all increased the proportion of OCT4 and NANOG-
positive cells with respect to vehicle control at statistically
significant levels as the concentration of drug increased, until
the concentration of drug became toxic. Toxicity varied with
each drug (indicated by crucifixes in Fig. 3B). These results with
clotrimazole and chlorpromazine were independently con-
firmed in another hESC line, RCM1 (data not shown).
Confirmation of the effect of calcium modulating
drugs on intracellular signal transduction in a
defined medium
Lastly, we assessed by Western immunoblotting whether
treatment with calcium modulating drugs activated both
anticipated intracellular signal transduction pathways
(Calmodulin and CaMKII) and those commonly implicated
in embryonic stem cell renewal (ERK, SMAD2 and STAT-3).
RH1 hESC were treated with a single concentration of drugs
for 10 min, and 3 and 24 h in each of three independent
experiments at a concentration observed to increase the
proportion of OCT4/NANOG positive cells after 7 days in the
previous experiment. Treatments were in mTESR lacking
both bFGF and TGF-β and compared with the absence of
these growth factors, with or without DMSO (the vehicle forFigure 3 Independent confirmation that G protein and intrace
maintenance. (A) (i) Rat GnRH receptor transgenic RH1 subclones cou
(clone 3.2) on the basis of intracellular calcium elevation in response
unit ratio (RFU) over time. (ii) Culture of GnRHR transgenic hESC cl
containing 4 ng/ml bFGF (HDF-CM+) or not (HDF-CM-) with GnRH at 20,
a significant (pb0.05) GnRH-associated increase in AP+ colony frequ
HDF-CM− (ii). (B) Treatment of RH1 hESCs for 7 days with small mol
10 nM), Clotrimazole (3, 10, 30 μM, and Chloropromazine (3, 10, 30 μM
(mTESR) lacking (−) bFGF. (i) Representative immunocytochemical sta
were imaged for each of 4 independent wells per condition) for OCT4 (
and DAPI-stained DNA (nuclei, blue) for increasing concentrations of e
primary antibody omitted (i.e. unstained) control cells. See Table S2
except LPA which was water soluble. Depending on the agent a
(ii). Acapella-based automated quantification of fluorescence staining
nuclei compared to respective vehicle controls arbitrarily set at a val
NANOG positive cells in a concentration dependent manner relative
(non-significant increase) at subcytotoxic levels. Triangles indicate in
significant increase in the proportion of OCT4/NANOG double positive
at a generally toxic level. The range of compound concentrations (sha
and did not exceed the IC/EC50 (half-maximal inhibitor/activating) coall drugs except water soluble LPA) and either or both
growth factors (Fig. 4). Pathway activation was defined by
elevation of substrate phosphorylation normalised against non-
phosphorylated SHPT2, as compared with negative controls.
After 3 and 24 h, there were no apparent or significant
differences between any of the treatment and control groups
(data not shown). Treatment for 10 min with most drugs and
growth factors resulted in non-significant elevation in the
phosphorylation of most substrates, the least of which being
SMAD2. Statistically significant elevationswere observed for the
phosphorylation of Calmodulin and Stat-3 in response to LPA,
and Stat-3 following treatment with TGF-β alone or together
with bFGF (pb0.05).
Discussion
Our study evaluated the significance of G protein-coupled
signalling pathways on undifferentiated hESC maintenance
under self-renewing conditions using a spectrum of pharma-
cological drugs and small molecules (the effects of which are
summarised in Fig. 5). In a primary screen using established
pharmacological drugs and alkaline phosphatase staining as a
surrogate marker of stemness we implicated downstream
elements of the Gα-q/11 subunit pathway, specifically PLCβ,
intracellular free calcium, [Ca++]i, and CAMKII kinase, as well
as the Gα-i/o subunit as of particular significance for mainte-
nance of this phenotype. By contrast, perturbation of the Gαs-
AC–PKA pathway had more general affects on total cell
growth and/or viability. The significance of free intracellular
calcium signalling was confirmed in independent experiments
demonstrating i) correlation with other stemness markers
(SSEA4), ii) the potential to compensate for an absence of
exogenously supplied bFGF following agonist-mediated activa-
tion of a transgenic hESC line expressing an exogenous Gα-q/11
subunit-coupled GPCR, iii) the ability of small molecule drugs
known to elevate intracellular free calcium to substitute for
bFGF in a defined medium, and iv) the ability of at least one of
these drugs to elevate phosphorylation of anticipated (Calmod-
ulin) and stem cell renewal relevant (Stat-3) substrates . Our
study thus substantiates a previously unappreciated role forllular free calcium signalling promote undifferentiated hESC
ld be discriminated as responders (clone 4.2) or non-responders
to GnRH ligand, as assessed by Fura2/Fluo3 relative fluorescence
ones for 7 days in human dermal fibroblast-conditioned medium
200 or 500 nM (solid bars) or vehicle alone (clear bars), resulted in
ency normalised to total cells only in the responder clone 4.2 in
ecule SERCA inhibitors CPA (0.5, 2.5, 10 μM), Thapsigargin (1, 3,
) in DMSO vehicle or LPA (10 nM, 100 nM, 1 μM) in definedmedium
ining (one example field of 36 is shown; 9 non-overlapping fields
green), NANOG (red), OCT4/NANOG double positive (yellow) cells
ach treatment (vertical gradient) and control, as compared with
for concentrations of vehicle for each concentration of all drugs
nd its final concentration this ranged from 0.0075 to 0.1%.
. Graph depicting the relative proportion of OCT4/NANOG positive
ue of 1. We observed significantly elevated proportions of OCT4/
to respective vehicle controls for all drugs except thapsigargin
creasing concentration of drug. Asterisks indicate a statistically
cells (*=p≤0.05, **=p≤0.01); crucifixes indicate that the drug is
ded triangle) tested was as summarised in Supplementary table 1
ncentration for each compound.
Figure 4 Assessment of signal transduction pathway activation in hESCs following treatment with intracellular calcium modulating
drugs and self-renewal sustaining growth factors. Representative western immunoblot (A) and normalised quantification from three
independent experiments evaluating phosphorylation status of intracellular signal transducing substrates commonly implicated in
calcium signalling, ESC renewal and differentiation (B). RH1 hESCs were treated for 10 min in an mTESR base medium lacking bFGF
and TGF-β to which carrier vehicle, drugs or growth factors were added as follows: DMSO at 0.01% as a vehicle control for all drugs
except for LPA, no growth factors (Neg), 10 μM of Clotrimazole (Clot.), 2.5 μM of Cyclopiazonic acid (CPA), 3 μM of Chlorpromazine
(ChloroP.), 100 nM Lysophosphatidic acid (LPA), 1 nM of Thapsigargin (Thaps), 15 ng/ml TGF-β (no bFGF), 15 ng/ml bFGF (no TGF-β)
or both growth factors at 15 ng/ml (positive control, Pos.). Assessment of the phosphorylation status of Calmodulin, CaMKII, SMAD2,
ERK and STAT3, normalised against non-phosphorylated SHPT2 revealed significant increases in phosphorylation of Calmodulin and
Stat-3 in response to LPA, and Stat-3 in response to TGF-β, and both bFGF and TGF- β, compared with the negative control (no growth
factors) (pb0.05).
180 A. Ermakov et al.calcium-mediated signal transduction in undifferentiated hESC
maintenance and further studies to manipulate these pathways
to support long term hESC maintenance and pluripotency.
Our primary screen involving 6 days of sustained treatment
with a spectrum of pharmacological agents served to indicate
the general significance of G protein-linked signal transduction
pathways to hESCs. Thus, cholera toxin, an activator of Gαs,
causing activation of AC had no effect on cell growth/viability
generally or undifferentiated hESC maintenance specifically, at
the concentrations evaluated (0.1–5 μg ml−1). However, both
treatment with forskolin, which activates AC, and pertussis
toxin, which inhibits the AC inhibitor Gαi/o interfered with cell
growth/viability. These findings suggest that in hESCs grown
under self-renewal conditions, Gαs is not particularly important
for self-renewal whereas sustained elevation of cAMP can
interfere with cell growth/viability generally. This was
corroborated by the observation that interference with PKA,
whose activation would be stimulated by elevated cAMP,
promoted cell growth. Our results contrast with the available
evidence highlighting a role for the Gαs-AC–PKA pathway inmouse ESC renewal. In mouse ESCs, cAMP and PKA have been
implicated in self-renewal in the absence of LIF signalling
(Faherty et al., 2007). Stimulation of Gαs protein by cholera
toxin during differentiation in embryoid bodies increased cell
proliferation and prevented the time-related decline in
pluripotency transcription factors (Layden et al., 2010).
Forskolin has also been reported as a key factor in stabilising a
LIF-dependent mESC-like phenotype in hESCs following trans-
duction with OCT4, Sox2 and Klf4. This effect was executed at
least partly through induction of Klf2 and Klf4 expression
(Hanna et al., 2010).
The inhibitory effect of pertussis toxin on cell viability was
apparent at low and intermediate concentrations (100 and
200 ng ml−1) whereas at high concentration (500 ng ml−1), it
negatively affected undifferentiated hESC maintenance only.
Pertussis toxin catalyses the ADP-ribosylation of Gαi/o, thereby
precluding GTP exchange and dissociation of the Gα subunit
from the Gβ and Gγ subunits which normally follows GPCR-
mediated activation. Pertussis toxin has previously been
shown to antagonise Sphingosine-1-phosphate (S1P) and
Figure 5 Schematic summary of putative G protein signalling pathway involvement in hESC maintenance and growth, integrating
outcome of experiments performed in feeder-conditioned and biologically defined media. Agonists, antagonists (stars coupled to →
or ⊥, respectively) with independently replicated statistically significant stimulatory (↑) or inhibitory (↓) effects on undifferentiated
hESCs (A) and total cells (B) are depicted in relation to their G protein signalling pathway target with their consequent stimulatory
(→) or inhibitory (⊥) effects to both denoted in bold. Our study suggests that inhibition of Gα i/o, Gα-q/11, PLC β, free calcium
chelation and CAMKII kinase can inhibit undifferentiated hESC maintenance whereas treatments with agents with the potential to
increase intracellular free calcium concentration through blockage of its sequestration into membranous organelles (CPA, Thapsigargin,
Clotrimazole and Chloropromazine) or activation of GPCRs (LPA) can promote it in a culture system dependent manner. Stimulation of
PKC can also interfere with hESC maintenance suggesting that this pathway operates in opposition to the calcium-dependent signalling
downstream of PLC. In contrast, modulation of all Gα and Gα i/o subunit and PKC signal transduction and free intracellular calcium via
Calcineurin can affect total cell counts, the net effect of altered growth, viability and attachment of undifferentiated and differentiating
cells.
181Role for G-Protein and calcium signalling in hESCsPDGF stimulation of hESC self-renewal in serum-free culture,
the former being a ligand of Gαi/o-coupled receptors (Pebay et
al., 2005). In self-renewal culture conditions equivalent to
those used in our study but involving only treatments over
2 days (not 6 as in our study), it has been reported that
treatment of hESCs and induced pluripotent stem cells (iPSCs)with pertussis toxin altered colonymorphology and organisation
but did not affect cell proliferation, apoptosis, expression of
pluripotency markers or ability to differentiate into germinal
lineages in vitro (Nakamura et al., 2009). In the same study,
effects on colony morphology were not apparent following
treatment with the Gαs activator, cholera toxin, which was also
182 A. Ermakov et al.consistent with our findings. In mouse, S1P stimulates mESC
renewal via activation of extracellular signal-regulated ERK1
and ERK2. This can be inhibited by both pertussis toxin,
affecting Gαi/o, as well as by inhibition of PKC, downstream of
the Gα-q/11 pathway (Rodgers et al., 2009).
In our evaluation of the Gαq-PLCβ-PKC pathway, treat-
ment with agonist (kisspeptin), or a negative allosteric
modulator (MPEP) of specific Gα-q/11-coupled GPCRs had no
significant effects on either total cell growth/viability or
undifferentiated hESC renewal, despite detection of tran-
scripts encoding receptors for these ligands in hESC tran-
scriptome data sets. The general inhibitor of Gα-q/11 itself
(YM-254890) also had no effects, suggesting that like Gαs,
GPCR-mediated stimulation of this G protein may not
normally be involved in undifferentiated hESCs or differen-
tiating hESC growth/viability, at least in the specific
context of the conditioned medium culture system used in
our screen. However, we observed that activation of an
exogenously supplied Gα-q/11 subunit-coupled GPCR could
compensate for a lack of exogenously supplied bFGF. This
substantiated further effort to manipulate downstream
signal transduction. Consistent with the hypothesis that
signalling pathways downstream Gα-q/11 could mediated
hESC renewal pan-inhibition of PLC by U73122 or activation
of PKC by PMA appeared to inhibit undifferentiated hESC
maintenance and total cell growth. To our knowledge, our
study is the first to implicate opposing roles for PLC and PKC
in undifferentiated hESC maintenance. PKC is a heteroge-
neous family of phospholipid-dependent kinases, subdivid-
ed into three groups: classical isoforms (α, β, γ) containing
domains which confer regulation by diacylglycerol (DAG)
and Ca++, novel isoforms (δ, ε, θ, η) which are Ca++ insensi-
tive, and atypical isoforms (ζ, λ/ι) which do not respond to
either. In mESCs, inhibitors of PKC-δ sustain self renewal
under hypoxic conditions which promote a limited early
differentiation in the presence of LIF (Lee et al., 2010;
Powers et al., 2008). PLC is a class of enzymes that
hydrolyse phosphopholipids yielding DAG and inositol tri-
phosphate, the latter of which in turn stimulates the release
of Ca++ from intracellular stores. In mammals, there are 13
types of PLC classified into six classes (β, γ, δ, ε, ζ, η)
according to structure, of which the predominant forms are
PLC-β and -γ. To confirm the pan-PLC-directed effect of
U73122, we tested its “inactive” analogue, U73343. With
the exception of lowest concentration of U73122 that only
affected hESC maintenance, the “inactive" analogue exer-
ted the same effects. In mouse microglial cells U73122, but
not the U73343 analogue, inhibited transient intracellular
Ca++ release from intracellular stores normally mediated by
PLC activation. However, both drugs inhibited a sustained
increase in intracellular Ca++ prior to or after activation of
ATP-gated surface membrane ion channels (Takenouchi et
al., 2005). The differential and common effects of these
drugs may reflect effects on the availability of intracellular
versus extracellular Ca++.
We further observed that agents bound to elevate in-
tracellular free Ca++ concentration promoted undifferentiated
hESCmaintenance specifically and total cell growth generally in
a dose and culture system dependent manner. This included a
range of sarco/endoplasmic reticulum Ca++-ATPases in-
hibitors anticipated to interfere with Ca++ sequestration
into membranous compartments, thereby artificially elevatingfree intracellular levels. Consistent with these findings was the
observation that undifferentiated (SSEA4+) cells in hESC
cultures had significantly higher [Ca++]i compared to the
differentiated (SSEA4−) cells in the culture, a difference
which ceased to be significant when cultures were treated
with the SERCA inhibitor thapsigargin. In mouse ESCs, intracel-
lular fee calcium oscillations are predominantly confined to and
important for the G1/S cell cycle transition, during which cells
can undergo lineage commitment (Kapur et al., 2007). Within
the context of hESCs, paracrine signalling between differenti-
ating and undifferentiated cells within a colony is understood to
underpin bFGF mediated support of self-renewal, although the
significance and nature of paracrine signalling may be culture
system dependent (Bendall et al., 2007). Further investigation
is warranted as to what role calcium signalling plays in this,
ideally in a minimal essential medium to facilitate interpreta-
tion such as for example E8 medium consisting of only
8 components (DMEM/F12, FGF2, TGF-beta, Insulin, Transfer-
rin, Selenium, NaHCO2 and L-ascorbic acid (Chen et al., 2011).
Exploration of paracrine signalling events would also benefit
from greater control in the delivery of bio-active factors than is
currently achieved through conventional solubilisation in
culture media. Recently we have described an alternative
method to sustain mouse embryonic stem cell renewal through
paracrine stimulation achieved by the affinity targeted delivery
of LIF in biodegradable nanoparticles (Corradetti et al.,
2012). This approach could be useful to deliver bio-active
molecules to specific cell sub-populations and dissect inter
and intracellular signal transduction pathway stimulation and
interactions.
In our experiments in mTESR, a complex medium which is at
least more biologically defined than fibroblast conditioned
medium supplemented with a serum replacement (i.e. KOSR™)
used in our primary screen, SERCA inhibitors and LPA, promoted
undifferentiated hESC stemness. Only LPA stimulated a signif-
icant increase in the phosphorylation of Calmodulin and STAT3.
Phosphorylation of the latter was also evident for TGF-β alone
or together with bFGF. LPA is a bio-active lysophospholipid and
GPCR ligand like S1P. It can be generated extracellularly and
intracellularly by various pathways and its effects are depen-
dent on the differential expression of its receptors and the G
proteins they are linked with. Many of its signalling effects are
mediated through the activation of extracellular signal-
regulated kinases 1/2, PLC, small GTPases, calcium mobili-
sation and activation or inhibition of adenylate cyclase ((Lee et
al., 2007); reviewed by (Pitson and Pebay, 2009)). LPA can also
act as an intracellular second messenger via the nuclear
transcription factor peroxisome proliferator-activated receptor
γ (PPARγ) (McIntyre et al., 2003). In human ESCs there are at
least 6 receptors for LPA and 5 for S1P, most of which appear to
be expressed. Notable among LPA receptors is LPA4 (also known
as GPR23) which according to a meta-analysis of the hESC
transcriptome is specifically enriched in hESCs (Assou et al.,
2007). In mouse ESCs LPA induces Ca++ mobilisation and c-myc
expression via PLC (Todorova et al., 2009). To our knowledge,
no biological effects of LPA on hESC have been previously
reported (Pebay et al., 2005; reviewed by Pitson and Pebay,
2009). LPA has been shown to activate Stat3 in other cell types
(Seo et al., 2010), as has Gαs and Gα-q mediated signal
transduction (reviewed by (Callihan et al., 2011)).
Our inability to detect significant effects of the SERCA
inhibitors on the phosphorylation status of calcium signal
183Role for G-Protein and calcium signalling in hESCstransducing and stem cell renewal associated substrates
probably related to the masking effects of signal transduc-
tion elicited by other growth factor and components in
mTESR medium, namely Lithium Chloride, GABA, Pipecolic
Acid, and insulin (Ludwig et al., 2006). Differential outcomes
in our primary screen following interference with calcineurin
vs CAMKII kinase suggest that general (i.e. cell proliferation
and viability) and specific roles (stem cell renewal) for Ca++
may be discriminatable at this juncture, although further
work is needed to dissect the network of relevant effectors
including specific and/or overlapping roles for the different
SERCA and IP3 receptors which are expressed. In addition to
its SERCA inhibitory activity, chlorpromazine also has some
CAMKII inhibitory activity, possibly explaining why this drug
only appeared to promote self renewal at low concentra-
tions. CAMKII kinases are multi-functional regulators of
transcription factors, glycogen metabolism and neurotrans-
mitter secretion. They are distinct in possessing an autocat-
alytic activity which serves as a molecular memory device
whose effect persists long after its activation (Braun and
Schulman, 1995). This raises the interesting possibility that
stimulation of hESC renewal could be achieved by periodic
activation of CAMKII signalling. Investigating this would also
benefit from technology enabling better control of paracrine
cell stimulation in vitro.Conclusion
It has only been in the last few years that it has been possible to
control pluripotent stem cell renewal and differentiation using
chemical modulators of intracellular signalling pathways
(reviewed by (Ng and Surani, 2011)). In mESCs independence
from LIF can be achieved using inhibitors of the FGF/ERK and
glycogen synthetase kinase-3 (GSK3) signalling pathways
(Nichols and Smith, 2009). Our study implicates Gα-i/o- and
Gα-q/11-subunit-mediated signalling, notably PLCβ, calcium
and CAMKII kinase in short term hESC culture. Activation of
Gα-q/11-subunit coupled GPCR elevates intracellular free
calcium and compensates for reduced bFGF. Small molecule
modulators of intracellular free calcium also appear to
substitute for bFGF and we provide evidence that LPA phos-
phorylates Calmodulin and STAT3, as does TGF-β when
presented alone or together with bFGF. Further investigation
of second messenger pathways affecting calcium homeostasis
are needed in minimally defined media supportive of hESC
renewal together with strategies for controlling paracrine
signalling in vitro. This will contribute to the development of
chemically-defined systems supportive of human pluripotent
stem cell renewal.List of abbreviations and conventions for paper
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